Efficacy of neck treatment in patients with head and neck squamous cell carcinoma

被引:15
|
作者
Buck, Gabriela [2 ]
Huguenin, Pia [1 ,3 ]
Stoeckli, Sandro J.
机构
[1] Univ Zurich Hosp, Clin Otorhinolaryngol Head & Neck Surg, CH-8091 Zurich, Switzerland
[2] Spital Zollikerberg, Dept Internal Med, Zollikerberg, Switzerland
[3] Rat Kantons & Regionalspital, Dept Radiat Oncol, Chur, Switzerland
关键词
neck dissection; head and neck squamous cell carcinoma; adjuvant radiation; neck treatment; lymph node metastasis;
D O I
10.1002/hed.20657
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. Treatment of head and neck squamous cell carcinoma (HNSCC) addresses the primary tumor and the lymphatic drainage. Modalities for the neck are neck dissection and/or radiation therapy. In most cases, the neck is treated by the modality that seems more appropriate for the primary. The aim of this study was to analyze the results of the neck treatments either by neck dissection alone, by radiation therapy alone or by neck dissection followed by radiation therapy. Methods. This was a retrospective chart analysis of 699 patients treated for a previously untreated HNSCC. The primary endpoint was recurrence at the treated neck. Results. Two hundred eighty-one (40%) patients underwent primary neck irradiation, 219 (31%) neck dissection alone, and 199 (29%) neck dissection followed by adjuvant irradiation. The 5-year regional control rates after neck dissection alone were 83% for pNO, 75% for pN1, 60% for pN2a, 59% for pN2b, and 50% for pN2c; after radiation alone. 89% for cNO, 87% for cN1, 40% for cN2a, 60% for cN2b, and 48% for cN2c; and after neck dissection with adjuvant radiation, 86% for pNO, 96% for pN1, 100% for pN2a, 88% for pN2b, and 88% for pN2c. Conclusions. Radiation or neck dissection alone are efficient to control early neck disease. For advanced N2/3 neck disease, neck dissection followed by adjuvant radiation is highly efficient, whereas primary radiation results in a high number of regional failures. The literature suggests planned neck dissection to improve regional control for these patients. (c) 2007 Wiley Periodicals, Inc.
引用
收藏
页码:50 / 57
页数:8
相关论文
共 50 条
  • [21] Treatment with cisplatin and vinorelbine in patients with squamous cell carcinoma of the head and neck.
    De la Llaba, J
    García, AL
    Aranda, F
    Barncío, IC
    Méndez, MI
    Aranda, E
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S64 - S64
  • [22] The Role of Neck Dissection in Squamous Cell Carcinoma of the Head and Neck
    Hamoir, Marc
    Schmitz, Sandra
    Gregoire, Vincent
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2014, 15 (04) : 611 - 624
  • [23] The Role of Neck Dissection in Squamous Cell Carcinoma of the Head and Neck
    Marc Hamoir
    Sandra Schmitz
    Vincent Gregoire
    Current Treatment Options in Oncology, 2014, 15 : 611 - 624
  • [24] The role of brachytherapy in the treatment of squamous cell carcinoma of the head and neck
    Wierzbicka, Magorzata
    Bartochowska, Anna
    Strnad, Vratislav
    Strojan, Primoz
    Mendenhall, William M.
    Harrison, Louis B.
    Rinaldo, Alessandra
    Sahai, Puja
    Wiegand, Susanne
    Ferlito, Alfio
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2016, 273 (02) : 269 - 276
  • [25] The role of brachytherapy in the treatment of squamous cell carcinoma of the head and neck
    Małgorzata Wierzbicka
    Anna Bartochowska
    Vratislav Strnad
    Primož Strojan
    William M. Mendenhall
    Louis B. Harrison
    Alessandra Rinaldo
    Puja Sahai
    Susanne Wiegand
    Alfio Ferlito
    European Archives of Oto-Rhino-Laryngology, 2016, 273 : 269 - 276
  • [26] Current surgical treatment of squamous cell carcinoma of the head and neck
    Yao, Mike
    Epstein, Joel B.
    Modi, Bijal J.
    Pytynia, Kristen B.
    Mundt, Arno J.
    Feldman, Lawrence E.
    ORAL ONCOLOGY, 2007, 43 (03) : 213 - 223
  • [27] Antibiotics may interfere with nivolumab efficacy in patients with head and neck squamous cell carcinoma
    Ueta, Reio
    Imai, Hiroo
    Saijo, Ken
    Kawamura, Yoshifumi
    Kodera, Shuto
    Komine, Keigo
    Ouchi, Kota
    Kasahara, Yuki
    Taniguchi, Sakura
    Yoshida, Yuya
    Sasaki, Keiju
    Shirota, Hidekazu
    Takahashi, Masanobu
    Ishioka, Chikashi
    ONCOLOGY, 2024, 102 (03) : 252 - 259
  • [28] TREATMENT OF SQUAMOUS CELL CARCINOMA OF HEAD AND NECK WITH METHOTREXATE AND IRRADIATION
    FRIEDMAN, M
    DALY, JF
    AMERICAN JOURNAL OF ROENTGENOLOGY RADIUM THERAPY AND NUCLEAR MEDICINE, 1967, 99 (02): : 289 - &
  • [29] EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck
    Ranee Mehra
    Roger B. Cohen
    Paul M. Harari
    Current Oncology Reports, 2008, 10 : 176 - 184
  • [30] Treatment of Oligometastatic Disease in Squamous Cell Carcinoma of the Head and Neck
    Vincent, Aurora G.
    Wang, Weitao
    Shokri, Tom
    Ducic, Yadranko
    LARYNGOSCOPE, 2021, 131 (05): : E1476 - E1480